In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva CEO Erez Vigodman to Step Down - WSJ
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva chooses new CEO
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO Schultz: 'Proof Is In The Pudding' For US Biosimilars :: Generics Bulletin
Teva CEO: We have to launch new products - Globes
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Haaretz.com
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva's new CEO shakes up management, to combine divisions | Reuters
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Erez Vigodman steps down as Teva CEO
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva CEO Erez Vigodman steps down - Philadelphia Business Journal
Teva CEO Erez Vigodman Resigns
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO Erez Vigodman Steps Down | CHEManager
US Congress grills Teva CEO on Copaxone price hikes - Globes
President and CEO of North Wales' Teva Pharmaceutical Steps Down
Teva CEO on decimated share price: "It's rational enough from a market point of view"
